Kenvue stock rallies off record low after Trump press conference on alleged Tylenol-autism link

by | Sep 23, 2025 | Stock Market

Kenvue stock rallied on Tuesday off a record low, after a White House press conference didn’t offer fresh evidence that could be used by plaintiffs to sue the maker of Tylenol for its alleged link to autism.

Article Attribution | Read More at Article Source